UNCLAIMED
Olink
Overview
Olink is a Swedish company founded in 2016 that operates within the Business Services industry, specifically focusing on research and development in proteomics. With a workforce of 201 to 500 employees, the company has generated revenue of approximately $170.9 million. Olink specializes in advanced proteomic technologies that facilitate the understanding of molecular regulation in various biological contexts, particularly in neurological disorders. Their Olink® Explore platform, which utilizes Proximity Extension Assay (PEA) technology, allows for high-throughput protein biomarker analysis from small sample volumes. A recent technical study highlighted the platform's effectiveness in analyzing brain tissue lysates, demonstrating high technical precision and reproducibility in detecting neurologically relevant proteins. This capability positions Olink as a significant contributor to the identification of biomarkers and therapeutic targets in the field of neurology, underlining the importance of integrating proteomics with other omics approaches to enhance insights into disease biology.